Home » Breast cancer radiation treatment reduced to a single dose

Breast cancer radiation treatment reduced to a single dose

Breast cancer radiation treatment reduced to a single dose

DALLAS – July 24, 2018 – For 81-year-old Marilyn Gibson, it was a no-brainer: Would she be interested in having a single dose of radiation to treat her breast cancer instead of the standard, multiple-dose treatment delivered over several weeks?

Mrs. Gibson elected to be part of a UT Southwestern Medical Center clinical trial testing a one-time, high-dose and highly focused radiation treatment called stereotactic radiotherapy for early-stage breast cancer. The Arlington resident said the single-dose option works well for someone at her stage of life, who limits their driving, though she could imagine it being equally attractive to a busy younger woman who’s juggling family and work.

“I want to get through it. I want to get over it, and this will be my one big contribution to mankind,” Mrs. Gibson said.

CyberKnife :  robotic radiation machine

Dr. Asal Rahimi, Assistant Professor, Director of Clinical Research, and a member of the Harold C. Simmons Comprehensive Cancer Center, said standard radiation treatment for breast cancer ranges from 16-33 radiation treatments delivered to the entire breast over a period of three to six weeks. Single-dose radiation is less disruptive to patients’ lives.

 “We have taken the concept of a single dose of radiation delivered to the tumor area intraoperatively and are trying to make it accessible to the general radiation-oncology public using the CyberKnife, which is a robotic radiation machine that can treat a focused point.”

Harold C. Simmons Comprehensive Cancer Center

The Harold C. Simmons Comprehensive Cancer Center, one of 49 NCI-designated Comprehensive Cancer Centers in the U.S. and the only one in North Texas, is among just 30 U.S. cancer research centers to be designated by the NCI as a National Clinical Trials Network Lead Academic Participating Site.

About Dr. Asal Rahimi

Asal Rahimi, M.D.  Director of Clinical Research  Assistant Professor

Dr. Rahimi is a highly trained board-certified radiation oncologist and a key member of the breast cancer care team at UT Southwestern. She joined the team in August 2011 after concluding her residency in radiation oncology at the University of Virginia and completing special training with the American Brachytherapy Society that same year.

Radiation treatment after surgery

While some medical centers are treating breast cancer with a single dose of radiation at the time of surgery, the protocol being tested at UT Southwestern delivers the radiation treatment after surgery has been completed, Dr. Rahimi said.

 “The advantage of treating after a lumpectomy is that we can be sure the margins are clear and that we know the status of the lymph nodes, so we can be certain the patient is a good candidate for partial breast radiation. Doing radiation intraoperatively, you are not always sure what the final pathology is going to be.”

After the surgery, the patient returns to the medical center for the placement of small gold seeds called fiducials, which are guides for where the radiation needs to go. About a week later, the patient returns for the treatment, which is a very high dose of radiation delivered to a very focal, localized area.

“Not every woman lives in a city where she has access to a radiation-oncology suite, so we have women that we see who live hours away who come to UT Southwestern for medical care,” Dr. Rahimi said. “We have women who come from different states to be treated here because they want these shorter courses so they have less disruption of their lives.”

Mrs. Gibson said her treatment was painless and pleasant.

“They played music the whole time. I actually went to sleep twice in my process.”

Radiation oncologist Dr. Asal Rahimi and patient Marilyn Gibson
Radiation oncologist Dr. Asal Rahimi and patient Marilyn Gibson

The clinical trial is looking at three different dosage levels of radiation. Patients are monitored for several years after their treatment.

This study builds on prior work that examined treating early-stage breast cancer with five stereotactic radiation treatments. That study, published in 2017, found that the shorter course of radiation treatments had a favorable toxicity profile and good cosmetic results. UT Southwestern has been a national leader in establishing stereotactic ablative radiotherapy, also known as SAbR, as standard treatment for prostate cancer and other cancers.

According to the National Cancer Institute (NCI), 266,120 women are expected to be diagnosed with breast cancer in 2018. More than half of all breast cancer cases – 62 percent – are diagnosed early, before the cancer has spread to the lymph nodes. The five-year survival rate for breast cancer diagnosed in this early, localized stage is 99 percent, according to the NCI.

Mrs. Gibson said the clinical trial suited her personal goals. “I wanted it to be quick. I wanted it to be effective.”

But there was another reason she signed up for the trial: It’s her way of giving back, of advancing science and medicine.

“This research is so important, so I’m in the right place. There’s no question about that. Oh, my gosh, I am lucky. Lucky. I am just so lucky that we were here,” Mrs. Gibson said.


About हस्तक्षेप

Check Also

भारत में 25 साल में दोगुने हो गए पक्षाघात और दिल की बीमारियों के मरीज

25 वर्षों में 50 फीसदी बढ़ गईं पक्षाघात और दिल की बीमांरियां. कुल मौतों में से 17.8 प्रतिशत हृदय रोग और 7.1 प्रतिशत पक्षाघात के कारण. Cardiovascular diseases, paralysis, heart beams, heart disease,

Bharatendu Harishchandra

अपने समय से बहुत ही आगे थे भारतेंदु, साहित्य में भी और राजनीतिक विचार में भी

विशेष आलेख गुलामी की पीड़ा : भारतेंदु हरिश्चंद्र की प्रासंगिकता मनोज कुमार झा/वीणा भाटिया “आवहु …

राष्ट्रीय संस्थाओं पर कब्जा: चिंतन प्रक्रिया पर हावी होने की साजिश

राष्ट्रीय संस्थाओं पर कब्जा : चिंतन प्रक्रिया पर हावी होने की साजिश Occupy national institutions : …

News Analysis and Expert opinion on issues related to India and abroad

अच्छे नहीं, अंधेरे दिनों की आहट

मोदी सरकार के सत्ता में आते ही संघ परिवार बड़ी मुस्तैदी से अपने उन एजेंडों के साथ सामने आ रहा है, जो काफी विवादित रहे हैं, इनका सम्बन्ध इतिहास, संस्कृति, नृतत्वशास्त्र, धर्मनिरपेक्षता तथा अकादमिक जगत में खास विचारधारा से लैस लोगों की तैनाती से है।

National News

ऐसे हुई पहाड़ की एक नदी की मौत

शिप्रा नदी : पहाड़ के परम्परागत जलस्रोत ख़त्म हो रहे हैं और जंगल की कटाई के साथ अंधाधुंध निर्माण इसकी बड़ी वजह है। इस वजह से छोटी नदियों पर खतरा मंडरा रहा है।


गंगा-एक कारपोरेट एजेंडा

जल वस्तु है, तो फिर गंगा मां कैसे हो सकती है ? गंगा रही होगी कभी स्वर्ग में ले जाने वाली धारा, साझी संस्कृति, अस्मिता और समृद्धि की प्रतीक, भारतीय पानी-पर्यावरण की नियंता, मां, वगैरह, वगैरह। ये शब्द अब पुराने पड़ चुके। गंगा, अब सिर्फ बिजली पैदा करने और पानी सेवा उद्योग का कच्चा माल है। मैला ढोने वाली मालगाड़ी है। कॉमन कमोडिटी मात्र !!

Entertainment news

Veda BF (वेडा बीएफ) पूर्ण वीडियो | Prem Kahani – Full Video

प्रेम कहानी - पूर्ण वीडियो | वेदा BF | अल्ताफ शेख, सोनम कांबले, तनवीर पटेल और दत्ता धर्मे. Prem Kahani - Full Video | Veda BF | Altaf Shaikh, Sonam Kamble, Tanveer Patel & Datta Dharme

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: